These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 38033722)

  • 1. Quantitative mass spectrometric analysis of hepatocellular carcinoma biomarker alpha-fetoprotein.
    Chen CC; Huang HW; Chen BR; Wong CH
    RSC Chem Biol; 2023 Nov; 4(12):1073-1081. PubMed ID: 38033722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measuring fucosylated alpha-fetoprotein in hepatocellular carcinoma: A comparison of μTAS and parallel reaction monitoring.
    Kim KH; Lee SY; Baek JH; Lee SY; Kim JY; Yoo JS
    Proteomics Clin Appl; 2021 Jul; 15(4):e2000096. PubMed ID: 33764665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of serum alpha fetoprotein-L3 as an accuracy novel biomarker for the early diagnosis of hepatocellular carcinoma in Egyptian patients.
    Ibrahim HM; Elghannam MZ; Elkhawaga OAY; El-Sokkary AMA
    Saudi J Biol Sci; 2021 Oct; 28(10):5760-5764. PubMed ID: 34588888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The fucosylation index of alpha-fetoprotein and its usefulness in the early diagnosis of hepatocellular carcinoma.
    Aoyagi Y; Suzuki Y; Isemura M; Nomoto M; Sekine C; Igarashi K; Ichida F
    Cancer; 1988 Feb; 61(4):769-74. PubMed ID: 2448024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct Monitoring of Fucosylated Glycopeptides of Alpha-Fetoprotein in Human Serum for Early Hepatocellular Carcinoma by Liquid Chromatography-Tandem Mass Spectrometry with Immunoprecipitation.
    Kim KH; Lee SY; Hwang H; Lee JY; Ji ES; An HJ; Kim JY; Yoo JS
    Proteomics Clin Appl; 2018 Nov; 12(6):e1800062. PubMed ID: 29888876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intramolecular fluorescence resonance energy transfer strategy for accurate detection of AFP-L3% and improved diagnosis of hepatocellular carcinoma.
    Liu Y; Han G; Gong J; Hua X; Zhu Q; Zhou S; Jiang L; Li Q; Liu S
    Spectrochim Acta A Mol Biomol Spectrosc; 2023 Nov; 300():122950. PubMed ID: 37295202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Highly enhanced fucosylation of serum glycoproteins in patients with hepatocellular carcinoma.
    Naitoh A; Aoyagi Y; Asakura H
    J Gastroenterol Hepatol; 1999 May; 14(5):436-45. PubMed ID: 10355508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and potential application of a simultaneous multiplex assay of Golgi protein 73 and alpha-fetoprotein for hepatocellular carcinoma diagnosis.
    Xiao J; Long F; Peng T; Hu LB; Cai H; Chen R; Chen WL
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3302-3310. PubMed ID: 31081083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Input of serum haptoglobin fucosylation profile in the diagnosis of hepatocellular carcinoma in patients with non-cirrhotic liver disease.
    Peta V; Zhu J; Lubman DM; Huguet S; Imbert-Bismutd F; Bolbach G; Clodic G; Matheron L; Ngo Y; Raluca P; Housset C; Rezai K; Poynard T;
    Clin Res Hepatol Gastroenterol; 2020 Oct; 44(5):681-691. PubMed ID: 31964615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carbohydrate-based measurements on alpha-fetoprotein in the early diagnosis of hepatocellular carcinoma.
    Aoyagi Y
    Glycoconj J; 1995 Jun; 12(3):194-9. PubMed ID: 7496131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of α-fetoprotein-L3 and Golgi protein 73 detection in diagnosis of hepatocellular carcinoma.
    Jia Z; Wang L; Liu C; Yu Z; Chai L; Zhao M
    Contemp Oncol (Pozn); 2014; 18(3):192-6. PubMed ID: 25520580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced detection of early hepatocellular carcinoma by serum SELDI-TOF proteomic signature combined with alpha-fetoprotein marker.
    Chen L; Ho DW; Lee NP; Sun S; Lam B; Wong KF; Yi X; Lau GK; Ng EW; Poon TC; Lai PB; Cai Z; Peng J; Leng X; Poon RT; Luk JM
    Ann Surg Oncol; 2010 Sep; 17(9):2518-25. PubMed ID: 20354800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic value of AFP-L3 and PIVKA-II in hepatocellular carcinoma according to total-AFP.
    Choi JY; Jung SW; Kim HY; Kim M; Kim Y; Kim DG; Oh EJ
    World J Gastroenterol; 2013 Jan; 19(3):339-46. PubMed ID: 23372355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined detection of circulating tumor cells, α-fetoprotein heterogene-3 and α-fetoprotein in the early diagnosis of HCC for the prediction of efficacy, prognosis, recurrence after microwave ablation.
    Zhou J; Zhu Y; Li Y; Liu K; He F; Xu S; Li X; Li L; Hu J; Liu Y
    Infect Agent Cancer; 2021 May; 16(1):28. PubMed ID: 33971914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum alpha-fetoprotein as a predictive biomarker for tissue alpha-fetoprotein status and prognosis in patients with hepatocellular carcinoma.
    Wei Z; Zhang Y; Lu H; Ying J; Zhao H; Cai J
    Transl Cancer Res; 2022 Apr; 11(4):669-677. PubMed ID: 35571648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PIVKA-II serves as a potential biomarker that complements AFP for the diagnosis of hepatocellular carcinoma.
    Feng H; Li B; Li Z; Wei Q; Ren L
    BMC Cancer; 2021 Apr; 21(1):401. PubMed ID: 33849479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Golgi Protein 73 versus Alpha-Fetoprotein as a New Biomarker in Early Diagnosis of Hepatocellular Carcinoma.
    Ali OM; El Amin HA; Sharkawy YL; Mohamed Ali AA; Kholef EFM; Elsewify WAE
    Int J Gen Med; 2020; 13():193-200. PubMed ID: 32547160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma fucosyltransferase activity in patients with hepatocellular carcinoma, with special reference to correlation with fucosylated species of alpha-fetoprotein.
    Mita Y; Aoyagi Y; Suda T; Asakura H
    J Hepatol; 2000 Jun; 32(6):946-54. PubMed ID: 10898315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in the Glycosylation of Kininogen and the Development of a Kininogen-Based Algorithm for the Early Detection of HCC.
    Wang M; Sanda M; Comunale MA; Herrera H; Swindell C; Kono Y; Singal AG; Marrero J; Block T; Goldman R; Mehta A
    Cancer Epidemiol Biomarkers Prev; 2017 May; 26(5):795-803. PubMed ID: 28223431
    [No Abstract]   [Full Text] [Related]  

  • 20. [Usefulness of serum alpha-fetoprotein (AFP) as a marker for hepatocellular carcinoma (HCC) in hepatitis C virus related cirrhosis: analysis of the factors influencing AFP elevation without HCC development].
    Kim KA; Lee JS; Jung ES; Kim JY; Bae WK; Kim NH; Moon YS
    Korean J Gastroenterol; 2006 Nov; 48(5):321-6. PubMed ID: 17132920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.